Monitoring the flexor hallucis brevis muscle using acceleromyography and underestimating the residual muscle relaxant effect: An observational study

Monitoring the flexor hallucis brevis muscle using acceleromyography and underestimating the residual muscle relaxant effect: An observational study - Lower limb AMG underestimate residual block

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1090220107

Enrollment

Registered

2012-12-20

Start date

2005-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergo elective surgery without neuromuscular diseases

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients underwent elective surgery without neuromuscular disease

Exclusion criteria

Exclusion criteria: Patients with renal and/or liver dysfunction

Design outcomes

Primary

Measure	Time frame
The differences in recovery from vecuronium induced neuromuscular block untill TOFR 0.7, 0.9 using electromyography at the first dorsal interosseous muscle of the upper limb and acceleromyography at the flexor hallucis brevis muscle of the lower limb.	—

Countries

Japan

Contacts

Public ContactYasuyuki Sugi

Fukuoka university

ysugi@fukuoka-u.ac.jp+81-92-801-1011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026